The new name emphasizes the focus on transparency and accountability in clinical trial services
RTP, NC — iNNO Clinical today announced it is changing its name to Aperio Clinical Outcomes, to better reflect the company’s dedication to delivering comprehensive clinical research services with unmatched transparency. The change will be effective on January 24, 2018.
Aperio Clinical Outcomes provides both comprehensive and customizable clinical research services across multiple therapeutic areas. In addition, Aperio offers consulting services in quality assurance, strategic resourcing, and practical application of the latest technologies being implemented in clinical trials.
Faye Woolf, founder and CEO of Aperio, is an industry expert with over 25 years of experience in clinical trials. Faye’s commitment is clear: “At Aperio, we’ll tell you plainly what we’re going to do: build the right team, establish strong relationships with sites and clients, and devote ourselves to honest interaction every step of the way. And then we’ll do it, always keeping the human element at the forefront. That’s how we deliver the results our clients deserve”
Woolf says that she created Aperio in response to what she has seen in the clinical trials sector. “Experience has taught us that being open and honest, following through on what we say, and valuing and supporting people at every step creates successful and lasting relationships — I’ve worked with some of the same people for more than 20 years. So our business was built on those principles, and they guide the work we do every day.”
The name Aperio comes from the Latin word for “uncover” or “reveal.” That focus on transparency in clinical trials begins with being clear upfront about what projects are a fit for Aperio’s capabilities, and extends through every step in the clinical trial process. “We’ll tell you the truth—no matter what,” says Woolf. “We won’t hide uncomfortable facts. We won’t use smoke and mirrors to distort reality. If Aperio can’t do an excellent job for you, we won’t take the work.”